Advertisement · 728 × 90

Posts by Gynuity Health Projects

Preview
Prognostic accuracy of clinical markers of postpartum bleeding in predicting maternal mortality or severe morbidity: a WHO individual participant data meta-analysis Measured blood loss below the conventional threshold, combined with abnormal haemodynamic signs, accurately predicts women at risk of death or life-threatening complications from postpartum bleeding a...

ICYMI recent @thelancet.com @who.int @hrpresearch.bsky.social papers re-evaluating conventional criteria for identifying & managing postpartum hemorrhage:

Individual Participant Data Meta-Analysis
www.thelancet.com/journals/lan...

Cost-Effectiveness Study
www.thelancet.com/journals/lan...

3 weeks ago 0 0 0 0
Preview
Setting research priorities for sexual and reproductive health in humanitarian settings: a global, stakeholder-informed agenda - Conflict and Health Background Sexual and reproductive health and rights (SRHR) remain critically underfunded and underresearched in humanitarian settings. Existing global research agendas are outdated, lack an implement...

Congratulations to all involved in this initiative to identify research priorities for reproductive health in humanitarian settings. We were pleased to join the priority-setting process. Read more in BMC Conflict and Health, Nam et al. link.springer.com/article/10.1...

2 months ago 1 1 0 0
President’s Message - Gynuity Health Projects

Sharing an account of our 2025 activities gynuity.org/annual-repor.... Read about collaborative research responding to the gap in number & type of abortion products; supporting omission of preabortion screening tests; fostering strategies to improve PPH outcomes.

2 months ago 0 0 0 0
Post image
4 months ago 0 0 0 0
Preview
Newsletter: Vol 9, No. 2, December 2025 Email from Gynuity Health Projects   ABOUT OUR WORK NEWS & EVENTS RESOURCES IMAGE BANK Introduction December 10th, 2025 In this issue, read about progress in our study to validate a medication abortio

Our latest newsletter myemail.constantcontact.com/Newsletter--...
▶️ a study to validate a medication abortion regimen using ulipristal acetate
▶️evidence & data from research helping to influence policy & practice decisions
▶️the impact of funding cuts on a study assessing a telemedicine care model

4 months ago 0 0 0 0
Gynuity’s President Honored with Special Award of Recognition for Contributions to Safe Abortion Access - Gynuity Health Projects

Gynuity’s president is honored with a Special Award of Recognition by the Georgian Society of Contraception & Reproductive Health for contributions to safe abortion access in the Republic of Georgia.This is really a lovely gesture from our colleagues in Tbilisi! Read more gynuity.org/news/gynuity...

5 months ago 0 0 0 0
Preview
Five Things to Know About Missed Period Pills Missed period pills bring back your period when it’s late and safely end a potential early pregnancy—no pregnancy test required.

Five Things to Know About Missed Period Pills, from @carafem.org and @msmagazine.com

6 months ago 16 8 1 1

3. Many people prefer to skip the test
A 2020 study by @gynuity.bsky.social found nearly half of the 678 participants would choose same-day pills without a pregnancy test—and 70% of those who didn’t want to be pregnant said the same. Many said that skipping the test would reduce stress and stigma.🧵

6 months ago 1 1 1 0
Video

Happy #PublicationDay, @rebeccakelliher.bsky.social! 🎆

JUST PILLS, the radical history of the abortion pills from invention to distribution to today, “is essential reading for anyone who cares about the attacks on our bodies and freedoms.” — @jessicavalenti.bsky.social

6 months ago 1 2 0 0
A flat lay photo shows a Mifeprex (mifepristone) box with a single round white pill and a green pill bottle with several white hexagonal tablets spilled out on a light circular background. Text above reads “Missed period pills,” and text below says, “A safe and evidence-backed way to bring back your period.” The design uses bold white and pink text on a dark green background.

A flat lay photo shows a Mifeprex (mifepristone) box with a single round white pill and a green pill bottle with several white hexagonal tablets spilled out on a light circular background. Text above reads “Missed period pills,” and text below says, “A safe and evidence-backed way to bring back your period.” The design uses bold white and pink text on a dark green background.

If your period is late & you don’t want to be pregnant, do you really have to wait for a positive pregnancy test before you can act? With missed period pills from carafem, you can take action to bring back your period & peace of mind by safely ending a potential early pregnancy.

6 months ago 1 1 1 0
Advertisement

Congratulations to everyone involved in this comprehensive analysis addressing important questions on excessive bleeding after childbirth >>>

6 months ago 0 0 0 0
Evita Solutions - Generic Mifepristone Available Today Evita Solutions LLC's FDA-approved generic Mifepristone Tablets, 200 mg for safe, effective medical abortion up to 70 days.

Welcome news. A new generic mifepristone product was approved for use by the US Food and Drug Administration in September 2025 for terminating an early pregnancy, up to 70 days from the first day of the last menstrual period
www.evitasolutionsllc.com

6 months ago 1 0 0 0

In reply to calls from prospective funders seeking to support abortion access/rights, we were identified as an impactful org working in this space www.bridgespan.org/insights/opp... If you'd like to explore your philanthropic journey with us, reach out to discuss how we can partner together

6 months ago 0 0 0 0
Newsletter: Vol 9, No. 1, September 2025 - Gynuity Health Projects

In the latest issue of our Newsletter gynuity.org/news/newslet..., read about ongoing research into ulipristal acetate for medication abortion, patient experiences with asynchronous medication abortion care, & a conference on advancing access to self-care interventions for reproductive health

6 months ago 0 0 0 0
Preview
The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and public health relevance, evidence of efficacy and...

The updated WHO List of Essential Medicines is available. For the first time, abortion medicines are presented in a new section &, in a positive move, the list no longer carries the caveat that singled out mifepristone & misoprostol as only to be used where legally permitted or culturally acceptable

7 months ago 0 0 0 0
Evaluation of a “Smart” Screening Tool for Asynchronous Assessment of Medication Abortion Eligibility: A Pilot Study - Gynuity Health Projects

This evaluation builds upon a study by @gynuity.bsky.social with @ppnorthcentral.bsky.social @pprockymountains.bsky.social, which suggests that providing medication abortion based only on a self-administered, programmed questionnaire is likely to be effective and safe gynuity.org/resources/ev...

7 months ago 0 0 0 0
“On my own time”: A qualitative exploration of patient experiences receiving asynchronous medication abortion care in the United States, 2022–2023 This study aimed to explore patient experience and support needs in receiving asynchronous medication abortion care without a real-time provider visit…

A qualitative study examining patient experiences with asynchronous medication abortion care in the US found that care without real-time interaction with a physician is highly acceptable to patients, enabling them to avoid unnecessary care with providers www.sciencedirect.com/science/arti...

7 months ago 0 0 1 0
Post image

📢 New: Abortion care guideline, 2nd edition

A consolidated reference of all WHO recommendations & best practices on abortion—covering law & policy, clinical services & service delivery.

🔗 bit.ly/45N7ehK

#SRHR #HealthForAll

7 months ago 5 2 0 0

Through this letter organized by CRHLP and ANSIRH, hundreds of researchers remind the FDA that it’s actions must be based on the sound, rigorous, and transparent science that conclusively proves the safety and effectiveness of mifepristone generally and via telehealth.

7 months ago 10 5 0 0
Advertisement

Today we and our colleagues at @‪ansirh.bsky.social‬ submitted a letter to the FDA for over 260 researchers affirming the 25-year safety record of mifepristone and urging the FDA not to restrict abortion pill access based on junk science. Read the letter here: law.ucla.edu/sites/defaul...

7 months ago 46 25 1 4
Preview
Center on Reproductive Health, Law, and Policy Reproductive Health Researchers Comment Letter to FDA On August 27th, 2025, UCLA Center on Reproductive Health, Law, and Policy (CRHLP) and Advancing New Standards in Reproductive Health (ANSIRH) at UCSF submitted a letter on behalf of more than 260 rese...

Today we submitted a letter with @uclarepropolicy.bsky.social to the FDA signed by over 200 scientists.

The short version? Medication abortion is safe. Time to drop the junk science and move on. law.ucla.edu/reproductive...

7 months ago 77 30 0 3

Congratulations to all behind TEACH's updated abortion training curriculum. Essential new resource >>>

9 months ago 2 0 0 0
FMUS Podcast Podcast for Feminism Makes Us Smarter

🎧In the FMUS podcast series, host @francoisegirard.bsky.social gets together with
@gynuity.bsky.social president Beverly Winikoff to discuss new groundbreaking research into ulipristal acetate for medication abortion. Tune into Ep. 13 www.fmus.org/fmus-podcast

9 months ago 1 1 0 0
Preview
The FDA’s ‘data guy’ should trust the data on the abortion pill FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.

"Makary, who proudly calls himself a 'data guy' should have no trouble acknowledging that the science behind mifepristone is rock solid—and it hasn’t changed."

📣My new op-ed with @heyjane.com's Kiki Fredman that calls on @fda.gov to trust the data on the #abortion pill!

thehill.com/opinion/heal...

9 months ago 23 8 2 1

Este FAQ (preguntas frecuentes) también está disponible en español gynuity.org/assets/resou...

10 months ago 0 0 0 0

@carrienbaker.bsky.social's excellent tribute to the extraordinary Dr. Étienne-Émile Baulieu, the French scientist behind RU 486, also known as mifepristone >>>

10 months ago 0 0 0 0
Preview
Why the US aid cuts are a moment to prioritize reproductive health Why the US aid cuts are a moment to prioritize reproductive health

As the Trump administration cuts foreign aid, reproductive health leaders are urging donors to keep prioritizing women and girls.

10 months ago 1 1 0 0
Preview
The ‘Study’ Driving the FDA’s Abortion-Pill Agenda RFK Jr.’s affection for junk science has struck again.

I wrote for @theatlantic.com about the latest "data" RFK Jr. is using to advance bad policy. This time, he's coming for abortion. www.theatlantic.com/health/archi...

10 months ago 7 6 1 0
Advertisement
Preview
The Right to Abortion in Nepal: A Decades-Long Journey | Center for Reproductive Rights New documentary showcases the progress of abortion from criminalization to a fundamental, constitutional right. Documentary showcases the progress of abortion from criminalization to a fundamental, co...

Two decades ago in Nepal, a woman seeking an abortion would be denied care. Today, the right to abortion is guaranteed in Nepal’s Constitution. Check out this new documentary (23 mins) Collective Voyage: A tireless journey for ensuring the right to safe abortion in Nepal.

10 months ago 3 2 0 0
FAQ on Ulipristal Acetate: A Potential New Regimen for Medication Abortion - Gynuity Health Projects

Data from a published study support the potential of ulipristal acetate as an alternative medicine for medication abortion. We have compiled a list of Frequently Asked Questions to provide quick and accessible answers to common queries about our early-stage research>>> gynuity.org/resources/fa...

10 months ago 4 2 1 0